Hologic, Inc. (HOLX) Price/FCF Ratio: 17.18
Is Hologic, Inc.’s Price/FCF ratio high or low?
Hologic, Inc.'s Price/FCF ratio of 17.18 is 18% above its 5-year average of 14.57, around the middle of its 5-year range (6.61–24.99).
6.66% above its 12-month average of 16.11.
HOLX Price/FCF Ratio Chart
HOLX Average Price/FCF Ratio Chart
HOLX Current vs Average Price/FCF Ratio Chart
HOLX Price/FCF Ratio Metrics
PRICE/FCF RATIO
17.18
PRICE/FCF RATIO AVG TTM
16.11
PRICE/FCF RATIO AVG 3Y
18.13
PRICE/FCF RATIO AVG 5Y
14.57
PRICE/FCF RATIO AVG 10Y
17.55
PRICE/FCF RATIO AVG 15Y
17.13
PRICE/FCF RATIO AVG 20Y
32.00
CURRENT VS TTM AVG
+6.66%
CURRENT VS 3Y AVG
-5.22%
CURRENT VS 5Y AVG
+17.95%
CURRENT VS 10Y AVG
-2.10%
CURRENT VS 15Y AVG
+0.31%
CURRENT VS 20Y AVG
-46.32%
HOLX Competitors' Price/FCF Ratio
| NAME | MARKET CAP | PRICE/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Hologic, Inc. (HOLX) | $16.97B | 17.18 | 16.11 | 18.13 | 14.57 |
| Moderna, Inc. (MRNA) | $18.71B | N/A | 28.07 | 27.23 | 27.23 |
| Align Technology, Inc. (ALGN) | $12.27B | 17.86 | 19.10 | 31.12 | 40.55 |
| BioNTech SE (BNTX) | $22.39B | 14.57 | 36.28 | 10.84 | 14.33 |
| Mettler-Toledo International Inc. (MTD) | $22.82B | 28.85 | 31.25 | 31.11 | 35.99 |
| Waters Corporation (WAT) | $23.21B | 113.00 | 40.12 | 39.39 | 38.40 |
| Baxter International Inc. (BAX) | $10.49B | 14.65 | 40.14 | 31.04 | 30.32 |
| Charles River Laboratories International, Inc. (CRL) | $8.94B | 23.22 | 16.24 | 22.79 | 28.34 |
| Bio-Rad Laboratories, Inc. (BIO) | $7.92B | 22.25 | 22.31 | 39.27 | 47.56 |
| Veeva Systems Inc. (VEEV) | $26.31B | 52.43 | 30.62 | 33.98 | 39.46 |
Free Cash Flow Valuation
P/FCF Ratio
17.2
FCF Yield
5.82%
Hologic, Inc. Price/FCF Ratio Formula & Definition
P/FCF measures market price relative to free cash flow per share. Free cash flow is operating cash flow after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Hologic, Inc. Price/FCF Ratio FAQ
- What is the Price/FCF ratio for Hologic, Inc. (HOLX)?
- The Price/FCF ratio for HOLX stock is 17.18.
- Is Hologic, Inc.'s Price/FCF ratio high or low?
- Hologic, Inc.'s Price/FCF ratio of 17.18 is 18% above its 5-year average of 14.57, around the middle of its 5-year range (6.61–24.99).
- What is the TTM average Price/FCF ratio for Hologic, Inc. (HOLX)?
- The TTM average Price/FCF ratio for HOLX stock is 16.11.
- What is the 3Y average Price/FCF ratio for Hologic, Inc. (HOLX)?
- The 3Y average Price/FCF ratio for HOLX stock is 18.13.
- What is the 5Y average Price/FCF ratio for Hologic, Inc. (HOLX)?
- The 5Y average Price/FCF ratio for HOLX stock is 14.57.
- What is the 10Y average Price/FCF ratio for Hologic, Inc. (HOLX)?
- The 10Y average Price/FCF ratio for HOLX stock is 17.55.
- What is the 15Y average Price/FCF ratio for Hologic, Inc. (HOLX)?
- The 15Y average Price/FCF ratio for HOLX stock is 17.13.
- What is the 20Y average Price/FCF ratio for Hologic, Inc. (HOLX)?
- The 20Y average Price/FCF ratio for HOLX stock is 32.00.
Hologic, Inc. Price/FCF Ratio History
| DATE | PRICE/FCF RATIO |
|---|---|
| 2026-04-07 | 17.18 |
| 2026-04-06 | 17.18 |
| 2026-04-02 | 17.09 |
| 2026-04-01 | 17.08 |
| 2026-03-31 | 17.08 |
| 2026-03-30 | 17.07 |
| 2026-03-27 | 17.10 |
| 2026-03-26 | 17.10 |
| 2026-03-25 | 17.07 |
| 2026-03-24 | 17.07 |
| 2026-03-23 | 17.09 |
| 2026-03-20 | 17.04 |
| 2026-03-19 | 17.02 |
| 2026-03-18 | 16.98 |
| 2026-03-17 | 16.96 |
| 2026-03-16 | 16.98 |
| 2026-03-13 | 16.97 |
| 2026-03-12 | 17.00 |
| 2026-03-11 | 17.04 |
| 2026-03-10 | 17.07 |
| 2026-03-09 | 17.08 |
| 2026-03-06 | 17.11 |
| 2026-03-05 | 17.12 |
| 2026-03-04 | 17.10 |
| 2026-03-03 | 17.05 |
| 2026-03-02 | 17.05 |
| 2026-02-27 | 17.03 |
| 2026-02-26 | 17.00 |
| 2026-02-25 | 17.02 |
| 2026-02-24 | 17.03 |
| 2026-02-23 | 17.05 |
| 2026-02-20 | 17.04 |
| 2026-02-19 | 16.98 |
| 2026-02-18 | 16.99 |
| 2026-02-17 | 16.98 |
| 2026-02-13 | 16.96 |
| 2026-02-12 | 16.93 |
| 2026-02-11 | 16.97 |
| 2026-02-10 | 16.98 |
| 2026-02-09 | 16.95 |
| 2026-02-06 | 16.90 |
| 2026-02-05 | 16.88 |
| 2026-02-04 | 16.86 |
| 2026-02-03 | 16.86 |
| 2026-02-02 | 16.89 |
| 2026-01-30 | 16.93 |
| 2026-01-29 | 16.94 |
| 2026-01-28 | 18.29 |
| 2026-01-27 | 18.32 |
| 2026-01-26 | 18.32 |
| 2026-01-23 | 18.28 |
| 2026-01-22 | 18.30 |
| 2026-01-21 | 18.30 |
| 2026-01-20 | 18.30 |
| 2026-01-16 | 18.26 |
| 2026-01-15 | 18.27 |
| 2026-01-14 | 18.31 |
| 2026-01-13 | 18.24 |
| 2026-01-12 | 18.23 |
| 2026-01-09 | 18.24 |
| 2026-01-08 | 18.24 |
| 2026-01-07 | 18.26 |
| 2026-01-06 | 18.25 |
| 2026-01-05 | 18.21 |
| 2026-01-02 | 18.16 |
| 2025-12-31 | 18.14 |
| 2025-12-30 | 18.16 |
| 2025-12-29 | 18.15 |
| 2025-12-26 | 18.15 |
| 2025-12-24 | 18.15 |
| 2025-12-23 | 18.24 |
| 2025-12-22 | 18.25 |
| 2025-12-19 | 18.26 |
| 2025-12-18 | 18.25 |
| 2025-12-17 | 18.25 |
| 2025-12-16 | 18.27 |
| 2025-12-15 | 18.32 |
| 2025-12-12 | 18.27 |
| 2025-12-11 | 18.23 |
| 2025-12-10 | 18.23 |
| 2025-12-09 | 18.24 |
| 2025-12-08 | 18.23 |
| 2025-12-05 | 18.26 |
| 2025-12-04 | 18.23 |
| 2025-12-03 | 18.27 |
| 2025-12-02 | 18.23 |
| 2025-12-01 | 18.23 |
| 2025-11-28 | 18.26 |
| 2025-11-26 | 18.22 |
| 2025-11-25 | 18.24 |
| 2025-11-24 | 18.21 |
| 2025-11-21 | 18.11 |
| 2025-11-20 | 18.05 |
| 2025-11-19 | 18.07 |
| 2025-11-18 | 18.05 |
| 2025-11-17 | 17.81 |
| 2025-11-14 | 17.81 |
| 2025-11-13 | 17.84 |
| 2025-11-12 | 17.91 |
| 2025-11-11 | 17.92 |
| 2025-11-10 | 17.85 |
| 2025-11-07 | 17.80 |
| 2025-11-06 | 17.81 |
| 2025-11-05 | 17.83 |
| 2025-11-04 | 17.80 |
| 2025-11-03 | 17.79 |
| 2025-10-31 | 17.75 |
| 2025-10-30 | 17.76 |
| 2025-10-29 | 17.77 |
| 2025-10-28 | 17.78 |
| 2025-10-27 | 17.76 |
| 2025-10-24 | 17.77 |
| 2025-10-23 | 17.75 |
| 2025-10-22 | 17.76 |
| 2025-10-21 | 17.77 |
| 2025-10-20 | 17.26 |
| 2025-10-17 | 16.78 |
| 2025-10-16 | 16.45 |
| 2025-10-15 | 16.09 |
| 2025-10-14 | 15.83 |
| 2025-10-13 | 15.73 |
| 2025-10-10 | 16.27 |
| 2025-10-09 | 16.48 |
| 2025-10-08 | 16.41 |
| 2025-10-07 | 16.27 |
| 2025-10-06 | 16.17 |
| 2025-10-03 | 16.39 |
| 2025-10-02 | 16.31 |
| 2025-10-01 | 16.10 |
| 2025-09-30 | 16.21 |
| 2025-09-29 | 16.13 |
| 2025-09-26 | 16.14 |
| 2025-09-25 | 15.80 |
| 2025-09-24 | 15.95 |
| 2025-09-23 | 16.25 |
| 2025-09-22 | 16.16 |
| 2025-09-19 | 15.93 |
| 2025-09-18 | 16.40 |
| 2025-09-17 | 16.38 |
| 2025-09-16 | 15.21 |
| 2025-09-15 | 15.32 |
| 2025-09-12 | 15.48 |
| 2025-09-11 | 15.94 |
| 2025-09-10 | 15.73 |
| 2025-09-09 | 16.03 |
| 2025-09-08 | 15.98 |
| 2025-09-05 | 16.03 |
| 2025-09-04 | 15.95 |
| 2025-09-03 | 15.91 |
| 2025-09-02 | 16.00 |
| 2025-08-29 | 16.12 |
| 2025-08-28 | 16.00 |
| 2025-08-27 | 16.03 |
| 2025-08-26 | 16.00 |
| 2025-08-25 | 16.12 |
| 2025-08-22 | 16.40 |
| 2025-08-21 | 16.13 |
| 2025-08-20 | 16.52 |
| 2025-08-19 | 16.29 |
| 2025-08-18 | 16.16 |
| 2025-08-15 | 16.29 |
| 2025-08-14 | 16.35 |
| 2025-08-13 | 16.57 |
| 2025-08-12 | 16.32 |
| 2025-08-11 | 16.33 |
| 2025-08-08 | 16.35 |
| 2025-08-07 | 16.32 |
| 2025-08-06 | 16.07 |
| 2025-08-05 | 16.29 |
| 2025-08-04 | 16.31 |
| 2025-08-01 | 16.13 |
| 2025-07-31 | 16.05 |
| 2025-07-30 | 14.97 |
| 2025-07-29 | 15.21 |
| 2025-07-28 | 15.13 |
| 2025-07-25 | 15.32 |
| 2025-07-24 | 15.23 |
| 2025-07-23 | 15.19 |
| 2025-07-22 | 15.06 |
| 2025-07-21 | 14.67 |
| 2025-07-18 | 14.74 |
| 2025-07-17 | 14.75 |
| 2025-07-16 | 14.71 |
| 2025-07-15 | 14.57 |
| 2025-07-14 | 14.89 |
| 2025-07-11 | 15.14 |
| 2025-07-10 | 15.40 |
| 2025-07-09 | 15.17 |
| 2025-07-08 | 14.95 |
| 2025-07-07 | 14.83 |
| 2025-07-03 | 14.92 |
| 2025-07-02 | 15.04 |
| 2025-07-01 | 15.05 |
| 2025-06-30 | 15.01 |
| 2025-06-27 | 14.98 |
| 2025-06-26 | 15.00 |
| 2025-06-25 | 14.81 |
| 2025-06-24 | 14.93 |
| 2025-06-23 | 14.84 |
| 2025-06-20 | 14.85 |
| 2025-06-18 | 14.74 |
| 2025-06-17 | 14.78 |
| 2025-06-16 | 15.01 |
| 2025-06-13 | 14.92 |
| 2025-06-12 | 15.02 |
| 2025-06-11 | 14.88 |
| 2025-06-10 | 15.01 |
| 2025-06-09 | 14.87 |
| 2025-06-06 | 14.82 |
| 2025-06-05 | 14.53 |
| 2025-06-04 | 14.41 |
| 2025-06-03 | 14.52 |
| 2025-06-02 | 14.28 |
| 2025-05-30 | 14.32 |
| 2025-05-29 | 14.49 |
| 2025-05-28 | 14.68 |
| 2025-05-27 | 14.32 |
| 2025-05-23 | 12.50 |
| 2025-05-22 | 12.55 |
| 2025-05-21 | 12.63 |
| 2025-05-20 | 13.01 |
| 2025-05-19 | 13.00 |
| 2025-05-16 | 13.08 |
| 2025-05-15 | 12.84 |
| 2025-05-14 | 12.75 |
| 2025-05-13 | 13.16 |
| 2025-05-12 | 13.55 |
| 2025-05-09 | 13.07 |
| 2025-05-08 | 12.94 |
| 2025-05-07 | 12.77 |
| 2025-05-06 | 12.23 |
| 2025-05-05 | 12.15 |
| 2025-05-02 | 12.48 |
| 2025-05-01 | 11.92 |
| 2025-04-30 | 12.11 |
| 2025-04-29 | 12.15 |
| 2025-04-28 | 12.09 |
| 2025-04-25 | 12.07 |
| 2025-04-24 | 12.13 |
| 2025-04-23 | 12.10 |
| 2025-04-22 | 12.11 |
| 2025-04-21 | 11.85 |
| 2025-04-17 | 11.98 |
| 2025-04-16 | 11.76 |
| 2025-04-15 | 12.04 |
| 2025-04-14 | 12.25 |
| 2025-04-11 | 12.04 |
| 2025-04-10 | 11.90 |
| 2025-04-09 | 12.34 |
| 2025-04-08 | 12.17 |
| 2025-04-07 | 12.75 |
| 2025-04-04 | 12.67 |
| 2025-04-03 | 12.84 |
| 2025-04-02 | 12.60 |
| 2025-04-01 | 12.77 |
| 2025-03-31 | 12.86 |
| 2025-03-28 | 12.76 |
| 2025-03-27 | 12.97 |
| 2025-03-26 | 12.79 |
| 2025-03-25 | 12.65 |
Showing the most recent 260 of 4,681 data points. The chart above shows the full history.
Related Metrics
About Hologic, Inc.
Hologic, Inc. is a medical technology company focused on designing, producing, and marketing a diverse range of diagnostic tests, medical imaging systems, and surgical solutions. Its core mission is to enhance women's health through proactive detection and effective treatment, serving patients in the United States, across Europe, the Asia-Pacific region, and various other international markets. The company operates through four distinct business units: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. Within its Diagnostics segment, Hologic provides Aptima molecular diagnostic assays for identifying infectious microorganisms, alongside Aptima viral load tests for conditions like HIV, Hepatitis C, and Hepatitis B. It also offers Aptima and Panther Fusion SARS-CoV-2 assays for detecting the virus, the ThinPrep System for cytology applications, and the Rapid Fetal Fibronectin Test to help clinicians assess the likelihood of premature birth. Furthermore, the company supplies various diagnostic tests for Group B Streptococcus. The Breast Health division delivers advanced imaging and analytical solutions, including 2D and 3D digital mammography systems with accompanying reading workstations. This segment also features minimally invasive breast biopsy guidance systems and devices, products for marking and localizing breast biopsy sites, specimen radiology tools, ultrasound solutions, connectivity options, and products supporting breast-conserving surgical procedures. For GYN Surgical needs, Hologic offers the NovaSure Endometrial Ablation System, designed to manage abnormal uterine bleeding, and the MyoSure Hysteroscopic Tissue Removal System for the excision of uterine fibroids, polyps, and other pathologies. Additionally, the Fluent Fluid Management System facilitates liquid distention during diagnostic and operative hysteroscopic interventions. The Skeletal Health segment includes the Horizon DXA, a dual-energy X-ray system, and the Fluoroscan Insight FD mini C-arm, which is utilized for minimally invasive orthopedic surgical procedures. Hologic distributes its comprehensive product portfolio through a combination of its dedicated direct sales and service teams, as well as via independent distributors and sales representatives. Established in 1985, Hologic, Inc. maintains its corporate headquarters in Marlborough, Massachusetts.
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Paul Malenchini